Health Products

APO-Candesartan 16 mg (2015-05-01)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDosage formDIN, NPN, DIN-HIMStrength
KW0445
Recalling Firm
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
Marketing Authorization Holder
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
A. APO-Candesartan 16 mgTabletDIN 02365367Candesartan cilexetil 16 mg

Introduction

Recalled products
  1. APO-Candesartan 16 mg

Reason

Apotex initiated recall of one additional lot of APO-Candesartan due to out of specification results during stability testing for CAD-II impurity.

Depth of distribution

Wholesalers

Related alerts

Apotex Product Recall (2015-04-10)
2015-04-10 | Drugs
Type of communication: Recall

APO-Candesartan / HCTZ Product Recall (2015-05-19)
2015-05-19 | Drugs
Type of communication: Recall

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime